Jennifer Doudna and Emmanuelle Charpentier were awarded the Japan Prize today for their invention of the revolutionary gene-editing technology known as CRISPR-Cas9, which has swept into research labs around the world and is already yielding new therapies for cancer and hereditary diseases.Read more about Doudna awarded Japan Prize for invention of CRISPR gene editing
An initiative launched two years ago by UC Berkeley and UC San Francisco to use CRISPR-Cas9 gene editing to develop new disease therapies is expanding into research on the planet’s major crops and poorly understood microbiomes, with plans to invest $125 million in these areas over the next five...Read more about CRISPR research institute expands into agriculture, microbiology
Armand Paul Alivisatos will receive the 2017 NAS Award in Chemical Sciences. Alivisatos is a pioneer in the field of nanotechnology, with work that has had important ramifications for the development of renewable energy, biomedical imaging, light-emitting devices, and other fields.Read more about Alivisatos to receive the 2017 NAS Award in Chemical Sciences